Free Trial

Ionis Pharmaceuticals (IONS) SEC Filings & 10K Form

Ionis Pharmaceuticals logo
$34.01 +0.07 (+0.21%)
(As of 11/22/2024 ET)

Recent Ionis Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/14/2024
7:34 PM
BB BIOTECH AG (Filed by)
Ionis Pharmaceuticals (Subject)
Form SC 13G/A
11/13/2024
7:55 AM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144/A
11/08/2024
9:52 AM
Ionis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/06/2024
3:06 PM
Ionis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
10:15 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
5:39 PM
Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2024
5:42 PM
Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
5:01 PM
Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2024
5:01 PM
Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
4:19 PM
Ionis Pharmaceuticals (Filer)
Form 424B5
09/09/2024
3:33 PM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
3:23 PM
Ionis Pharmaceuticals (Filer)
Form 424B5
09/04/2024
8:43 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:43 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:51 PM
Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:23 PM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144/A
09/04/2024
8:24 PM
Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
Form 144/A
09/04/2024
8:25 PM
HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144/A
09/04/2024
8:27 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144/A
09/04/2024
8:29 PM
Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144/A
09/04/2024
8:33 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4/A
09/04/2024
8:33 PM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144/A
09/04/2024
8:40 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:40 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:41 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:19 PM
Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
Form 144/A
09/04/2024
8:20 PM
Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
Form 144/A
09/04/2024
8:21 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144/A
09/04/2024
8:02 PM
Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4/A
09/04/2024
8:06 PM
Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
Form 4/A
09/04/2024
8:11 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4/A
09/04/2024
8:13 PM
HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4/A
09/04/2024
7:51 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4/A
09/04/2024
7:52 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4/A
09/04/2024
7:42 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4/A
09/04/2024
7:42 PM
Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4/A
09/03/2024
6:18 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
4:27 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
2:35 PM
Ionis Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/01/2024
10:15 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2024
4:02 PM
BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)

Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?

07/17/2024
4:02 PM
Diaz Allene M. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:02 PM
HERMAN JOAN E (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:02 PM
Ionis Pharmaceuticals (Issuer)
KLEIN JOSEPH III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:03 PM
Ionis Pharmaceuticals (Issuer)
LOSCALZO JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:03 PM
Ionis Pharmaceuticals (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:03 PM
Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
3:11 PM
Diaz Allene M. (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2024
2:13 PM
Ionis Pharmaceuticals (Issuer)
YANG MICHAEL J. (Reporting)
Form 4/A
07/03/2024
1:48 PM
Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:48 PM
Ionis Pharmaceuticals (Issuer)
YANG MICHAEL J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:47 PM
BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:47 PM
Diaz Allene M. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:47 PM
Hayden Michael R (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:47 PM
HERMAN JOAN E (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:47 PM
Ionis Pharmaceuticals (Issuer)
KLEIN JOSEPH III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:47 PM
Ionis Pharmaceuticals (Issuer)
LOSCALZO JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:47 PM
Ionis Pharmaceuticals (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:52 PM
BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:29 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
9:59 AM
BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
3:33 PM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
6:15 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
4:25 PM
Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:55 PM
Ionis Pharmaceuticals (Issuer)
KLEIN JOSEPH III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
10:15 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
3:50 PM
Ionis Pharmaceuticals (Filer)
Form DEF 14A
04/25/2024
3:52 PM
Ionis Pharmaceuticals (Filer)
Form DEFA14A
04/25/2024
3:53 PM
Ionis Pharmaceuticals (Filer)
Form ARS
04/17/2024
4:16 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
4:19 PM
Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
7:59 PM
Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2024
7:50 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/08/2024
5:04 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
4:52 PM
Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/13/2024
4:52 PM
Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:13 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:13 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:13 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:13 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:13 PM
Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
8:10 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
3:38 PM
Ionis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/21/2024
10:17 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
9:39 AM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144/A
02/16/2024
6:47 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:34 PM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2024
5:09 AM
BB BIOTECH AG (Filed by)
Ionis Pharmaceuticals (Subject)
Form SC 13G/A
02/02/2024
6:54 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:54 PM
Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:54 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)

Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?

02/02/2024
6:55 PM
HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:55 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:55 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:55 PM
Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:55 PM
Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:31 PM
Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
4:34 PM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
4:21 PM
Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
4:23 PM
Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IONS) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners